China Pharmaceutical Consulting

As one of the world’s fastest growing healthcare markets today, China’s pharmaceutical market is worth about $40 billion and is projected to grow 15%-20% over the next five years. To enter the Chinese drug market, it is crucial for international companies to understand the healthcare environment in China. PBM has worked as a pharmaceutical consultant in China for numerous projects. We have provided consulting services to international drug clients with product registration, marketing and distribution of new drugs, sourcing APIs and establishing local manufacturing sites in China.

As China becomes more developed, its epidemiological profile is changing. Chinese people are eating more unhealthy Western fast foods, smoking more, and exercising less. Western chronic diseases are on the rise in China and now account for over 75% of deaths in the country. The leading causes of death in China are cardiovascular and cerebrovascular diseases (stroke). These two diseases combined account for 37% of deaths in China. This is followed by cancer (20%), and respiratory illnesses (18%).

Strong growth is expected in China’s prescription and over-the-counter (OTC) drug markets. China’s OTC market is expected to become the world’s largest within ten years. While there are many domestic Chinese pharmaceutical companies, foreign companies remain the dominant players in China’s patented drug market. Most domestic pharmaceutical companies in China are focused on producing generic drugs, with limited investment in research and development. International companies interested in expanding their drug business into China can turn to PBM’s pharmaceutical consultants for professional assistance.

China’s governing body for pharmaceutical products is the State Food and Drug Administration (SFDA). The SFDA, modeled after the US FDA, works under the control of the State Council. Apart from pharmaceutical products, the SFDA also regulates medical devices, food, and cosmetics. It also controls all registration, inspection, sale, research, and advertising for these medical products. Foreign companies will require the help of an experienced China pharmaceutical consultant to navigate through the Chinese pharmaceutical regulations for product approvals.

PBM’s China pharmaceutical consultants are dedicated professionals who work diligently to help international pharmaceutical companies succeed. With our knowledge and experience of the Chinese pharmaceutical industry, we can help you achieve your business goals.

For inquiries on PBM’s China pharmaceutical consultant services, please contact us or view PBM’s publications to find out more about the Chinese pharmaceutical market.